Latest filing published 28 Sept 2010 for Myriad Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Robert J. Lollini: trading record in brief
Robert J. Lollini has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Myriad Pharmaceuticals, Inc. and Iomed Inc. We count 3 filings; the first trade dates from 9 August 2007 and the latest from 24 September 2010.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 28 September 2010: a share grant, in Myriad Pharmaceuticals, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert J. Lollini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 22,167 shares0Common StockSEC:0001181431-10-048184:0
- 21,000 shares0Common StockSEC:0001181431-09-034345:0
- 9,756 shares@ US$2.75Common StockSEC:0001232787-07-000007:0
3 of 3 declarations
